Skip to content

Use of Calcium in various medical diseases

Cross-sectional analyses to assess the Real World Utilization of Calcium Supplements In Different Clinical State (TRACE Study) - TRACE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/12/060701
Enrollment
7808
Registered
2023-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E58- Dietary calcium deficiency

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Torrent Pharmaceuticals Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients must meet all of the following criteria for enrollment in the study: 1) Female or male patient 18 years and above. 2) Female or male patient having calcium deficiency symptoms in different clinical diagnosed cases.

Exclusion criteria

Exclusion criteria: If patients meeting any of the study exclusion criteria, should be excluded from study: 1) Contraindications to test product ingredients. 2) Any other condition or factor as per discretion of treating physician indicating that the patient is not suitable for the study.

Design outcomes

Primary

MeasureTime frame
Change in pain severity and prevalence of co-morbidities.Timepoint: From baseline (Day 0) to 3 months.

Secondary

MeasureTime frame
Most common observed adverse even ( >1%).Timepoint: 3 months;Preference of calcium supplement in different clinical state.Timepoint: From baseline (Day 0) to 3 months.

Countries

India

Contacts

Public ContactDr Rathish Nair PhD MBA

Torrent Pharmaceuticals Ltd

krishnaprasadkorukonda@torrentpharma.com7069000572

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026